Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Depression
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Depression
    Duloxetine, SSRIs Produce Similar Rates of Sexual Dysfunction in Patients With Depression: Presented at WCBP - (DGDispatch)
    TopAbstracts in Depression 07/01/2009 - (DGNews)
    Desvenlafaxine Reduces Anxiety Associated With Major Depressive Disorder: Presented at WCBP - (DGDispatch)
    Desvenlafaxine Is Effective for Major Depressive Disorder: Presented at WCBP - (DGDispatch)
    Armodafinil Improves Excessive Sleepiness Associated With Treated Obstructive Sleep Apnoea in Patients With Depression: Presented at ENS - (DGDispatch)

    News archive

     Recent webcasts/CME - Depression
      Treatment-Resistant Depression -- Part III: Switching Antidepressants vs. Conventional Augmentation Strategies
      On the Front Line of Major Depressive Disorder and Comorbidities: Managed Care and the Primary Care Physician
      Treatment-Resistant Depression -- Part II: Augmentation Strategies
      Treatment-Resistant Depression -- Part I: Introduction and Clinical Presentations
      Enhancing Treatment for Patients with Comorbid Depression, Diabetes and Heart Disease

      Webcasts/CME archive

       Recent cases - Depression
        Creutzfeldt-Jacob Disease Presenting as Severe Depression: A Case Report
        Sexual Dysfunction in a Young Mother
        Psychiatric Disorder Associated with Vacuum-Assisted Breast Biopsy Clip Placement: A Case Report
        A Postmenopausal Woman Presenting with Ekbom Syndrome Associated with Recurrent Depressive Disorder: A Case Report
        Affective Psychosis, Hashimoto's Thyroiditis, and Brain Perfusion Abnormalities: Case Report

        Cases archive
          




        my personal edition > depression > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Meta Analysis Shows Electroconvulsive Therapy May Be Justified For Depression Treatment

        Lancet

        03/06/2003
        By Harvey McConnell


        A systematic overview and meta analysis of published evidence supports the use of electroconvulsive therapy (ECT) as a short-term treatment for depression.

        The review of 73 randomised controlled trials and observational studies showed ECT treatment may be better than drug therapy as a short-term, declare Dr. John Geddes and colleagues at the University of Oxford, in England, and collaborators from the UK ECT Review Group.

        Their review involved trials comparing ECT with 'sham' ECT, ECT compared with drug therapy, bilateral ECT compared with unilateral ECT, and high-dose compared with low- dose ECT.

        Dr. Geddes and colleagues point out that ECT has been used in psychiatry since the 1930s. Views on ECT vary, from researchers who consider that it is probably ineffective but certainly causes brain damage, to those who think it is the most effective treatment available in psychiatry and is completely safe.

        The main outcome measures in the review were decreases in depressive symptoms after therapy, symptom status after 6-month follow-up, effect on cognitive function and on mortality.

        Real ECT was significantly more effective than simulated ECT (six trials, 256 patients) and significantly more effective than pharmacotherapy (18 trials, 1,144 patients). Bilateral ECT was more effective than unipolar ECT (22 trials, 1,408 patients) and high dose ECT was more effective than low dose.

        "It is clear that any attempt to simplify our findings to one strategy for all clinical situations (one size fits all) will be unhelpful," Dr Geddes and colleagues write. "Thus, it is not possible to recommend the exclusive routine use of either unilateral or bilateral ECT because it is likely that specific clinical circumstances may need one or the other."

        They concluded that "there is a reasonable evidence base for the use of ECT: it does not rest simply on anecdote, habit, and tradition. The trials that have been done reflect concerns that were uppermost at the time. In the 1970s, this concern was efficacy of electroshock per se, more recently it has been dose and site of shock administration. ECT remains an important treatment option for the management of severe depression."
        Lancet 2003;361:799-808.

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send